Rita Smith - 15 Mar 2026 Form 4 Insider Report for BEL FUSE INC /NJ (BELFB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Mar 2026, 16:46:38 UTC
Prior SEC filing
18 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lynn Hutkin

Key filing fact

Rita Smith filed Form 4 for BEL FUSE INC /NJ (BELFB) on 17 Mar 2026.

Key facts

  • This page summarizes Rita Smith's Form 4 filing for BEL FUSE INC /NJ (BELFB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Mar 2026, 16:46.

Change

  • Previous filing in this sequence was filed on 18 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001804761 Primary reporting owner

Smith Rita

Relationship
Director
Address
C/O BEL FUSE INC., 300 EXECUTIVE DRIVE, SUITE 300, WEST ORANGE
Signature
/s/ Lynn Hutkin
Signature date
17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BELFB transaction

Class B Common Stock

Award

Transaction value
Shares
+1,030
Change %
+21%
Price
$0.000000*
Shares after
5,827
Date
15 Mar 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Dr. Smith was granted 1,030 restricted shares of Class B Common Stock on March 15, 2026. The restricted shares vest as follows: 343 shares vest as of March 15, 2027; 343 shares vest as of March 15, 2028; and 344 shares vest as of March 15, 2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .